Premium
Case Reports. Invasive pulmonary aspergillosis in non‐neutropenic patients treated with liposomal amphotericin B
Author(s) -
Zhirong Y.,
Wanqing L.,
Weihua P.
Publication year - 1999
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1046/j.1439-0507.1999.00508.x
Subject(s) - aspergillosis , amphotericin b , medicine , aspergillus fumigatus , pulmonary aspergillosis , aspergillus flavus , adverse effect , neutropenia , lymphoma , gastroenterology , surgery , chemotherapy , dermatology , antifungal , immunology , microbiology and biotechnology , biology
We report two cases of invasive pulmonary aspergillosis due to Aspergillus flavus in one patient who with chronic nephritis and to A. fumigatus in another with malignant lymphoma. After receiving intravenous liposomal amphotericin B therapy for 31 and 35 days, respectively, the patients were cured and did not experience any severe adverse effects.